Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio
March 26 2014 - 8:44AM
Marketwired
Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on
Clear Channel Business Talk Radio
Interview Scheduled at 11:05am PDT / 12:05 pm MDT / 2:05pm EDT
on The Traders Network Radio Show, Hosted by Michael Yorba
RICHMOND, CA--(Marketwired - Mar 26, 2014) - Ekso Bionics
Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton pioneer, today
announced that CEO Nathan Harding will be interviewed live today by
host Michael Yorba on Clear Channel Business Talk Radio's The
Traders Network Show. Any interested parties may tune in and
listen live via Clear Channel's nationally syndicated iHeart Radio
stream.
The live interview details are as follows:
Date: Wednesday, March 26, 2014 Start Time: 11:05am PDT |
12:05pm MDT | 2:05pm EDT (U.S.) Network: Clear Channel Station: DFW
1190AM KFXR Show: The Traders Network Host: Michael Yorba Live
iHeart Radio Stream:
http://www.iheart.com/live/4276/?autoplay=true
About Clear Channel: Clear Channel's Media and Entertainment
division has the largest reach of any radio or television outlet in
America with 243 million monthly listeners. It serves 150 cities
through 850 owned radio stations in the U.S., as well as more than
140 stations in New Zealand and Australia.
www.clearchannel.com.
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and
featured host on Clear Channel. For the past six years he has
produced and hosted The Traders Network Show broadcasted live daily
on Clear Channel DFW 1190AM KFXR from 1pm - 3pm CT,
Monday-Friday.
Michael Yorba interviews the front-page Titans about the latest
in capital markets, CEO milestones, trading tools, real estate
acquisitions and market trends. Learn how the experts use risk
management techniques to build fully diversified portfolios and
what it takes to put up big board earnings. It's a fast moving,
high-energy show that presents stocks, commodities, bonds, forex,
derivatives, real estate, political trends, technology trends,
crowd funding and impact investment insights in a new light and
keeps audience asking for more... shift your thinking and join us
as we deliver "tomorrow's ideas today" on Clear Channel's The
Traders Network Show.
About Ekso Bionics (OTCQB: EKSO)
Since 2005, Ekso Bionics (http://www.eksobionics.com) has been
pioneering the field of robotic exoskeletons, or wearable robots,
to augment human strength, endurance and mobility. The company's
first commercially available product called Ekso has helped
thousands of people living with paralysis take millions of steps
not otherwise possible. By designing and creating some of the most
forward-thinking and innovative solutions for people looking to
augment human capabilities, Ekso Bionics is helping people rethink
current physical limitations and achieve the remarkable.
Facebook: www.facebook.com/eksobionics Twitter: @eksobionics
YouTube: http://www.youtube.com/user/EksoBionics/
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Forward-looking statements may include, without
limitation, statements regarding (i) the plans and objectives of
management for future operations, including plans or objectives
relating to the design, development and commercialization of human
exoskeletons, (ii) a projection of income (including income/loss),
earnings (including earnings/loss) per share, capital expenditures,
dividends, capital structure or other financial items, (iii) the
Company's future financial performance and (iv) the assumptions
underlying or relating to any statement described in points (i),
(ii) or (iii) above. Such forward-looking statements are not meant
to predict or guarantee actual results, performance, events or
circumstances and may not be realized because they are based upon
the Company's current projections, plans, objectives, beliefs,
expectations, estimates and assumptions and are subject to a number
of risks and uncertainties and other influences, many of which the
Company has no control over. Actual results and the timing of
certain events and circumstances may differ materially from those
described by the forward-looking statements as a result of these
risks and uncertainties. Factors that may influence or contribute
to the inaccuracy of the forward-looking statements or cause actual
results to differ materially from expected or desired results may
include, without limitation, the Company's inability to obtain
adequate financing, the significant length of time and resources
associated with the development of our products and related
insufficient cash flows and resulting illiquidity, the Company's
inability to expand the Company's business, significant government
regulation of medical devices and the healthcare industry, lack of
product diversification, volatility in the price of the Company's
raw materials, existing or increased competition, results of
arbitration and litigation, stock volatility and illiquidity, and
the Company's failure to implement the Company's business plans or
strategies. These and other factors are identified and described in
more detail in the Company's filings with the SEC, including, the
Company's Current Report on Form 8-K filed on January 23, 2014. The
Company does not undertake to update these forward-looking
statements.
A www.1800PublicRelations.com PR
Event
Contacts: EKSO Bionics Media Contact: Heidi Darling Marketing
Manager +1 (415) 302.4777 hdarling@eksobionics.com Investor
Contact: Lauren Glaser Vice President +1 (646) 378.2972
lglaser@troutgroup.com Press/Media Contact: Matthew Bird President
MUNCmedia Public Relations +1 (917) 409-8211
matt.bird@muncmedia.com www.muncmedia.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024